Melanoma and levodopa [3] (multiple letters)

Journal of the American Academy of Dermatology

Volumn 38, Issue 5 I, 1998, Pages 782-784

  Rampen, F ^a   Pfutzner, W ^a   Przybilla, B ^a  

^a ST ANNA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DOSE RESPONSE; HUMAN; LETTER; MELANOMA; PARKINSON DISEASE; PRIORITY JOURNAL; ULTRAVIOLET RADIATION; CHEMICALLY INDUCED DISORDER; NOTE; RISK FACTOR; SKIN TUMOR;

ANTIPARKINSON AGENTS; DOPAMINE AGONISTS; HUMANS; LEVODOPA; MELANOMA; PARKINSON DISEASE; RISK FACTORS; SKIN NEOPLASMS;

EID: 0032065623     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(98)70219-1     Document Type: Letter

References (15)